查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1957826

2026年全球脊椎生技药品市场报告

Spine Biologics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，脊椎生物製剂市场显着扩张。预计该市场将从2025年的24.7亿美元成长到2026年的26.1亿美元，复合年增长率为5.5%。过去几年的增长归因于多种因素，例如退化性脊椎疾病盛行率的上升、脊椎融合手术数量的增加、传统骨移植的限制、人口老化以及生物製药带来的手术效果改善。

预计未来几年脊椎生物製剂市场将稳定成长，到2030年将达到31.7亿美元，复合年增长率（CAGR）为5.0%。预测期内的成长要素包括：对再生医学解决方案的需求不断增长、微创脊椎手术的兴起、对减少术后併发症的日益重视、生物材料的技术进步以及整形外科医疗医疗费用支出的增加。预测期内的主要趋势包括：生物移植材料在脊椎融合手术中的应用日益广泛、合成骨移植替代品的使用范围扩大、微创脊椎手术越来越受欢迎、细胞疗法和再生医学在脊椎治疗中的应用不断扩展，以及对快速骨癒合解决方案的需求不断增长。

预计未来几年，交通事故发生率的上升将推动脊椎生物製药市场的成长。交通事故是指车辆在公共道路上发生的非故意碰撞，是需要先进生物治疗的创伤性脊椎损伤的主要原因。交通事故率上升的原因包括交通流量增加、驾驶注意力不集中、酒后驾驶、道路基础设施不足等。脊椎生物製药透过促进脊椎融合、加速骨骼癒合、减少手术併发症以及改善长期功能预后来支持患者復原。例如，根据总部位于法国的政府间组织－国际运输论坛（ITF）的数据，截至2025年8月，澳洲报告指出2024年交通事故死亡人数为1,297人，比2023年增加4%。因此，交通事故数量的增加正在推动脊椎生物製剂市场的扩张。

脊椎生物製剂市场的主要企业正致力于开发创新解决方案，例如再生生物製剂，以改善脊椎融合手术的疗效和手术效率。再生生物製剂是由天然或人工生物来源材料製成的医疗产品，有助于修復、再生和替代受损组织。例如，2025年10月，总部位于加拿大的製造商Aurora Spine Corporation宣布透过其专业部门Aurora Biologics推出一系列新的生物製剂产品，旨在提高脊椎融合手术的成功率。此系列产品包括100%同种异体骨移植产品，如TURBO FUSE纤维糊剂和OSTEO BRIDGE海绵条，旨在优化脊椎融合手术的疗效。这些生物製药与Aurora的微创脊椎移植技术结合，可提高手术效率并促进患者的长期復原。此次上市将使 Aurora 的生物製药范围扩大 30% 以上，加速成长，并支持公司简化复杂脊椎治疗的使命。

目录

第一章：执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球脊椎生技药品市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 生物技术、基因组学和精准医疗
    • 工业4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 永续性、气候技术、循环经济
  • 主要趋势
    • 脊椎融合手术中生物移植材料的使用日益增多
    • 增加合成骨移植替代品的使用
    • 人们越来越倾向选择微创脊椎手术
    • 利用细胞疗法和再生医学拓展脊椎治疗方法
    • 对更快骨癒合解决方案的需求日益增长

第五章 终端用户产业市场分析

  • 医院
  • 脊椎外科中心
  • 整形外科诊所
  • 门诊手术中心
  • 復健中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球脊椎生技药品市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球脊椎生技药品市场规模、比较及成长率分析
  • 全球脊椎生技药品市场表现：规模与成长，2020-2025年
  • 全球脊椎生技药品市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 副产品
  • 同种异体骨移植、骨移植替代品、骨髓穿刺疗法
  • 依手术类型
  • 前路颈椎间盘切除与椎间融合（ ACDF）、后路腰椎椎间融合（PLIF）、椎间椎间融合（TLIF）、前路腰椎椎间融合（ALIF）、侧路腰椎椎间融合（LLIF）以及其他手术类型。
  • 透过使用
  • 脊椎融合手术、脊椎不癒合和骨折修復、椎间盘退化性疾病的治疗及其他适应症
  • 最终用户
  • 医院、脊椎外科中心、整形外科诊所和其他最终用户
  • 按类型细分：同种异体骨
  • 活体同种异体移植，冷冻干燥同种异体移植
  • 按类型细分：骨移植替代方案
  • 合成骨移植材料、去矿物质骨基质（DBM）、磷酸钙基移植材料、富血小板血浆（PRP）
  • 依类型细分：骨髓穿刺疗法
  • 浓缩骨髓穿刺液，骨髓浓缩液

第十章 区域与国别分析

  • 全球脊椎生技药品市场：依地区划分，历史资料及预测（2020-2025年、2025-2030年、2035年）
  • 全球脊椎生技药品市场：按国家/地区划分，实际结果和预测，2020-2025 年、2025-2030 年预测、2035 年预测

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 脊椎生技药品市场：竞争格局与市场占有率（2024 年）
  • 脊椎生技药品市场：公司估值矩阵
  • 脊椎生技药品市场：公司概况
    • Medtronic PLC
    • Johnson & Johnson Services Inc.
    • Stryker Corporation
    • Zimmer Biomet Holdings Inc.
    • Integra LifeSciences Corporation

第37章 其他大型企业和创新企业

  • RTI Surgical Inc., LifeNet Health Inc., Xtant Medical Holdings Inc., Kuros Biosciences AG, Cerapedics Inc, Aziyo Biologics, Bone Biologics Corp., Orthofix Medical Inc., NuVasive Inc., SeaSpine Holdings Corporation, Exactech Inc., DePuy Synthes, Globus Medical Inc., Spine Wave Inc., Osiris Therapeutics Inc.

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年脊椎生技药品市场：提供新机会的国家
  • 2030年脊椎生技药品市场：充满新机会的细分市场
  • 2030年脊椎生技药品市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: PH4MSBIO02_G26Q1

Spine biologics, also referred to as spinal biologics, are materials derived from biological sources that are used to address spinal conditions and injuries. These materials help promote bone growth, accelerate healing, and enhance the results of spine surgeries, especially spinal fusion procedures. They encompass a range of products, including bone grafts, growth factors, cell-based therapies, and biological scaffolds.

The primary products in spine biologics include bone allografts, bone graft substitutes, platelet-rich plasma, and bone marrow aspirate therapy. Bone allografts are grafts obtained from a donor instead of the patient's own body. Various surgical procedures, such as anterior cervical discectomy and fusion (ACDF), posterior lumbar interbody fusion (PLIF), transforaminal lumbar interbody fusion (TLIF), anterior lumbar interbody fusion (ALIF), lateral lumbar interbody fusion (LLIF), and others, utilize spine biologics for applications including spinal fusion, spinal non-union and fracture repair, degenerative disc disease treatment, and more. These products are used by multiple end users, including hospitals, spinal surgery centers, orthopedic clinics, and others.

Tariffs have impacted the spine biologics market by increasing costs for imported biologic materials, processed bone grafts, and specialized surgical components. These effects are most pronounced in advanced biologic products and in regions dependent on cross-border medical material sourcing. Elevated tariffs may raise procedure costs and limit adoption in cost-sensitive healthcare systems. However, tariffs are also encouraging domestic production, local sourcing of graft materials, and innovation in synthetic

The spine biologics market research report is one of a series of new reports from The Business Research Company that provides spine biologics market statistics, including spine biologics industry global market size, regional shares, competitors with a spine biologics market share, detailed spine biologics market segments, market trends and opportunities, and any further data you may need to thrive in the spine biologics industry. This spine biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The spine biologics market size has grown strongly in recent years. It will grow from $2.47 billion in 2025 to $2.61 billion in 2026 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to increasing prevalence of degenerative spine disorders, rising number of spinal fusion surgeries, limitations of traditional bone grafts, growing aging population, improving surgical outcomes with biologics.

The spine biologics market size is expected to see steady growth in the next few years. It will grow to $3.17 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to expanding demand for regenerative medicine solutions, growth in minimally invasive spine surgeries, increasing focus on reducing post-surgical complications, technological advancements in biologic materials, rising healthcare spending on orthopedic care. Major trends in the forecast period include rising adoption of biologic bone grafts in spinal fusion, increasing use of synthetic bone graft substitutes, growing preference for minimally invasive spine procedures, expansion of cell-based and regenerative spine therapies, higher demand for faster bone healing solutions.

The increasing incidence of road accidents is anticipated to drive the growth of the spinal biologics market in the coming years. A road accident is an unintended collision involving vehicles on public roads and represents a significant cause of traumatic spinal injuries that often require advanced biologic treatments. The rise in road accident rates is attributed to factors such as higher traffic volumes, distracted driving, impaired driving, and insufficient road infrastructure. Spinal biologics aid patient recovery by promoting spinal fusion, accelerating bone healing, minimizing surgical complications, and enhancing long-term functional outcomes. For example, in August 2025, according to the International Transport Forum, a France-based intergovernmental organization, Australia reported 1,297 road deaths in 2024, representing a 4% increase compared to 2023. Consequently, the growing number of road accidents is contributing to the expansion of the spinal biologics market.

Major companies in the spinal biologics market are concentrating on developing innovative solutions, such as regenerative biologics, to enhance spinal fusion results and surgical efficiency. Regenerative biologics are medical products derived from natural or engineered biological materials that support the repair, regeneration, or replacement of damaged tissues. For example, in October 2025, Aurora Spine Corporation, a Canada-based manufacturing company, introduced a new biologics portfolio through a dedicated division called Aurora Biologics, aimed at improving spinal fusion success. This portfolio includes 100% allograft bone products like TURBO FUSE Fiber Putty and OSTEO BRIDGE Sponge Strips, designed to optimize spinal fusion outcomes. These biologics are combined with Aurora's minimally invasive spinal implant technologies, enhancing surgical efficiency and long-term patient recovery. The launch increases Aurora's biologics offerings by more than 30%, promoting growth and supporting their mission to simplify complex spine care.

In August 2023, Xtant Medical, a US-based medical technology company, acquired specific assets and liabilities related to domestic and international biologics and spinal fixation products from Surgalign Holdings Inc. for an undisclosed sum. This acquisition will enable the combined strengths of both companies to help Xtant Medical broaden its product portfolio and enhance its market presence in the orthopedic and spine surgery sectors. Surgalign Holdings Inc. is a US-based medical technology company that offers spine biologics and spinal fixation products.

Major companies operating in the spine biologics market are Medtronic PLC, Johnson & Johnson Services Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Integra LifeSciences Corporation, RTI Surgical Inc., LifeNet Health Inc., Xtant Medical Holdings Inc., Kuros Biosciences A.G., Cerapedics Inc, Aziyo Biologics, Bone Biologics Corp., Orthofix Medical Inc., NuVasive Inc., SeaSpine Holdings Corporation, Exactech Inc., DePuy Synthes, Globus Medical Inc., Spine Wave Inc., Osiris Therapeutics Inc.

North America was the largest region in the spine biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spine biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the spine biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The spine biologics market consists of sales of bone morphogenetic proteins, synthetic bone grafts, and spine fusion systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Spine Biologics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses spine biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for spine biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The spine biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Bone Allografts; Bone Graft Substitute; Platelet Rich Plasma; Bone Marrow Aspirate Therapy
  • 2) By Surgery Type: Anterior Cervical Discectomy And Fusion (ACDF); Posterior Lumbar Interbody Fusion (PLIF); Transforaminal Lumbar Interbody Fusion (TLIF); Anterior Lumbar Interbody Fusion (ALIF); Lateral Lumbar Interbody Fusion (LLIF); Other Surgery Types
  • 3) By Application: Spinal Fusion; Spinal Non-Union And Fracture Repair; Degenerative Disc Disease Treatment; Other Applications
  • 4) By End User: Hospitals; Spinal Surgery Centers; Orthopedic Clinics; Other End Users
  • Subsegments:
  • 1) By Bone Allografts: Fresh Allografts; Freeze-Dried Allografts
  • 2) By Bone Graft Substitute: Synthetic Bone Grafts; Demineralized Bone Matrix (DBM); Calcium Phosphate-Based Grafts; Platelet Rich Plasma (PRP)
  • 3) By Bone Marrow Aspirate Therapy: Concentrated Bone Marrow Aspirate; Bone Marrow Concentrates
  • Companies Mentioned: Medtronic PLC; Johnson & Johnson Services Inc.; Stryker Corporation; Zimmer Biomet Holdings Inc.; Integra LifeSciences Corporation; RTI Surgical Inc.; LifeNet Health Inc.; Xtant Medical Holdings Inc.; Kuros Biosciences A.G.; Cerapedics Inc; Aziyo Biologics; Bone Biologics Corp.; Orthofix Medical Inc.; NuVasive Inc.; SeaSpine Holdings Corporation; Exactech Inc.; DePuy Synthes; Globus Medical Inc.; Spine Wave Inc.; Osiris Therapeutics Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Spine Biologics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Spine Biologics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Spine Biologics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Spine Biologics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Biologic Bone Grafts In Spinal Fusion
    • 4.2.2 Increasing Use Of Synthetic Bone Graft Substitutes
    • 4.2.3 Growing Preference For Minimally Invasive Spine Procedures
    • 4.2.4 Expansion Of Cell-Based And Regenerative Spine Therapies
    • 4.2.5 Higher Demand For Faster Bone Healing Solutions

5. Spine Biologics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Spinal Surgery Centers
  • 5.3 Orthopedic Clinics
  • 5.4 Ambulatory Surgical Centers
  • 5.5 Rehabilitation Centers

6. Spine Biologics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Spine Biologics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Spine Biologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Spine Biologics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Spine Biologics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Spine Biologics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Spine Biologics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Spine Biologics Market Segmentation

  • 9.1. Global Spine Biologics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bone Allografts, Bone Graft Substitute, Bone Marrow Aspirate Therapy
  • 9.2. Global Spine Biologics Market, Segmentation By Surgery Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Anterior Cervical Discectomy And Fusion (ACDF), Posterior Lumbar Interbody Fusion (PLIF), Transforaminal Lumbar Interbody Fusion (TLIF), Anterior Lumbar Interbody Fusion (ALIF), Lateral Lumbar Interbody Fusion (LLIF), Other Surgery Types
  • 9.3. Global Spine Biologics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Spinal Fusion, Spinal Non-Union And Fracture Repair, Degenerative Disc Disease Treatment, Other Applications
  • 9.4. Global Spine Biologics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Other End Users
  • 9.5. Global Spine Biologics Market, Sub-Segmentation Of Bone Allografts, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fresh Allografts, Freeze-Dried Allografts
  • 9.6. Global Spine Biologics Market, Sub-Segmentation Of Bone Graft Substitute, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Synthetic Bone Grafts, Demineralized Bone Matrix (DBM), Calcium Phosphate-Based Grafts, Platelet Rich Plasma (PRP)
  • 9.7. Global Spine Biologics Market, Sub-Segmentation Of Bone Marrow Aspirate Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Concentrated Bone Marrow Aspirate, Bone Marrow Concentrates

10. Spine Biologics Market Regional And Country Analysis

  • 10.1. Global Spine Biologics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Spine Biologics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Spine Biologics Market

  • 11.1. Asia-Pacific Spine Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Spine Biologics Market

  • 12.1. China Spine Biologics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Spine Biologics Market

  • 13.1. India Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Spine Biologics Market

  • 14.1. Japan Spine Biologics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Spine Biologics Market

  • 15.1. Australia Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Spine Biologics Market

  • 16.1. Indonesia Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Spine Biologics Market

  • 17.1. South Korea Spine Biologics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Spine Biologics Market

  • 18.1. Taiwan Spine Biologics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Spine Biologics Market

  • 19.1. South East Asia Spine Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Spine Biologics Market

  • 20.1. Western Europe Spine Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Spine Biologics Market

  • 21.1. UK Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Spine Biologics Market

  • 22.1. Germany Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Spine Biologics Market

  • 23.1. France Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Spine Biologics Market

  • 24.1. Italy Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Spine Biologics Market

  • 25.1. Spain Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Spine Biologics Market

  • 26.1. Eastern Europe Spine Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Spine Biologics Market

  • 27.1. Russia Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Spine Biologics Market

  • 28.1. North America Spine Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Spine Biologics Market

  • 29.1. USA Spine Biologics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Spine Biologics Market

  • 30.1. Canada Spine Biologics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Spine Biologics Market

  • 31.1. South America Spine Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Spine Biologics Market

  • 32.1. Brazil Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Spine Biologics Market

  • 33.1. Middle East Spine Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Spine Biologics Market

  • 34.1. Africa Spine Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Spine Biologics Market, Segmentation By Product, Segmentation By Surgery Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Spine Biologics Market Regulatory and Investment Landscape

36. Spine Biologics Market Competitive Landscape And Company Profiles

  • 36.1. Spine Biologics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Spine Biologics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Spine Biologics Market Company Profiles
    • 36.3.1. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Integra LifeSciences Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Spine Biologics Market Other Major And Innovative Companies

  • RTI Surgical Inc., LifeNet Health Inc., Xtant Medical Holdings Inc., Kuros Biosciences A.G., Cerapedics Inc, Aziyo Biologics, Bone Biologics Corp., Orthofix Medical Inc., NuVasive Inc., SeaSpine Holdings Corporation, Exactech Inc., DePuy Synthes, Globus Medical Inc., Spine Wave Inc., Osiris Therapeutics Inc.

38. Global Spine Biologics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Spine Biologics Market

40. Spine Biologics Market High Potential Countries, Segments and Strategies

  • 40.1 Spine Biologics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Spine Biologics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Spine Biologics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer